 SAN CARLOS, Calif., May 03, 2022 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in and host one-on-one meetings at the following investor conferences: 